2
Views
0
CrossRef citations to date
0
Altmetric
Research Article

BROADSHEET NUMBER 54: HEREDITARY HEMOCHROMATOSIS

Pages 24-36 | Published online: 06 Jul 2009

  • Trousseau A. Anonymous Clinique Medicale de 1'Hotel-Dieu de Paris, 2nd: Glycosurie, diabete sucre. Paris: Balliere, 1865; 663.
  • von Recklinghausen FD. Taggeblet der (62) Versainumlung Deutsch Naturforscher und Arzte in Heidelberg. 1889; 324-5.
  • Sheldon JH. Haemochromatosis. London: Oxford University Press, 1935; 382
  • Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6(1): 24-9.
  • Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacterial 1962; 84: 53-64.
  • Feder JN, Gnirke A, Thomas W, et al. A novel MHC class -I like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
  • Powell LW, Leggett BA, Crawford DHG, et al., editors. Hemochromatosis and other iron storage disorders. In, Schiff's Diseases of the Liver, Eighth Edition. Philadelphia: Lippincott-Raven, 1998; in press.
  • Milman N. Hereditary haemochromatosis in Denmark 1950-1985: clinical, biochemical and histological features in 179 patients and 13 preclinical cases. Dan Mod Bull 1991; 38: 385-93.
  • Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997; 25: 162-6.
  • Lamon JM, Marynick SP, Roseblatt R, Donnelly S. Idiopathic hemochroamtosis in a young female. A case study and review of the syndrome in young people. Gastroenterology 1979; 76: 178-83.
  • Felts JH, Nelson JR, Herndon CN, Spurr CL. Hemochromatosis in two young sisters. Case studies and a family survey. Ann Intern Med 1967; 67: 117-23.
  • Charlton RW, Abrahams C, Bothwell TH. Idiopathic hemochromatosis in young subjects. Clinical, pathological, and chemical findings in four patients. Arch Pathol 1967; 83: 132-40.
  • Cazzola M, Ascari E, Claudiani G, et al. Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet 1983; 65: 149-54.
  • Camaschella C, Cicilano M, Bosio S, et al. Juvenile and adult hemochromatosis are distinct genetic disorders. Eur J Hum Genet 1997; 5: 371-5.
  • Knisely AS, Magid MS, Dische MR, Cutz E. Neonatal hemochromatosis. Birth Defects 1987; 23: 75-102.
  • Witzelbin CL, Uri A. Perinatal hemochromatosis: entity or end result? Hum Pathol 1989; 20 335-40.
  • Silver MM, Beverley DW, Valberg LS, et al. Perinatal hemochromatosis: clinical morphologic and quantitative iron studies. Am J Pathol 1987; 128: 538-54.
  • Verloes A, Temple IK, Hubert A, et al. Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers. J Med Genet 1996; 33: 444-9.
  • Rand EB, McClenathan DT, Whitington PF. Neonatal hemochromatosis: report of successful orthotopic liver transplantation. J Pediatr Gasroenterol Nutr 1992; 15: 325-9.
  • Knisely AS. Neonatal hemochromatosis. Adv Pediatr 1992; 39: 383-403.
  • MacDonald RA. Hemochromatosis and hemosiderosis. (Springfield, IL: Charles C. Thomas, 1964.
  • Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA A3 and HLA B14 antigens with idiopathic hemochromatosis. Gut 1976; 17: 332-4.
  • Walters JM, Watt DW, Stevens FM, McCarthy CF. HLA antigens in haemochromatosis. Br Med J 1975; 4: 520.
  • Simon M, Alexandre JL, Bourel M, et al. Heredity of idiopathic hemochromatosis: a study of 106 families. Clin Genet 1977; 11: 327-41.
  • Doran T, Bashir HV, Trejaut J, et al. Idiopathic hemochromatosis in the Australian population: HLA linkage and recessivity. Hum lmmunol 1981; 2: 191-200.
  • Ritter B, Safwenberg J, Olsson KS. HLA as a marker of the hemochromatosis gene in Sweden. Hum Genet 1984; 68: 62-6.
  • Summers KM, Tarn KS, Halliday JW, Powell LW. HLA determinants in an Australian population of hemochromatosis patients and their families. Am J Hum Genet 1989; 45: 41-8.
  • Santas M, Schilham MW, Rademakers LPHM, et al. Defective iron homeostasis in ß2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. / Exp Med 1996; 184: 1975-85.
  • Rothenberg BE, Voland JR. Beta-2-microglobulin knockout mice develop parenchyma! iron overload: a putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sei USA 1996; 93: 1529-34.
  • Carella M, D'Ambrosio L, Totaro A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60: 828-82.
  • Jazwinska EC, Cullen LM, Busfield F, etal. Haemochromatosis and HLA-H [letter]. Nat Genet 1996; 14: 249-51.
  • Jouanolle AM, Gandon G, Jezequel P, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14: 251-2.
  • Worwood M, Shearman JD, Wallace DF, et al. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997; 41: 841-4.
  • Bacon BR, Powell LW, Adams PC, et al. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999; 116: 193-207.
  • Edwards CQ, Griffin LM, Goldgar D, et al. Prevalence of hemocmomatosis among 11,065 presumably healthy blood donors. New Engl J Med 1988; 318(1): 1355-62.
  • Leggett BA, Halliday JW, Brown NN, et al. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 1990; 74: 525-30.
  • Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative haemochrornatosis mutations. J Med Genet 1997; 34: 275-8.
  • Cullen LM, Summerville L, Glassick TV, et al. Neonatal screening for the haemochromatosis defect. Blood 1997; 90: 423-7.
  • Roberts AG, Whatley SD, Morgan RR, et al. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-3.
  • Sampietro M, Piperno A, Lupica L, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria curtanea tarda. Hepatology 1998; 27: 181-4.
  • Stuart KA, Busfield F, Jazwinska EC, et al. The C282Y mutation in haemochromatosis (HFE) gene and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 1998; 28: 404-9.
  • George DK, Goldwurm S, Macdonald GA, et al. Increased hepatic iron stores on non alcoholic steatohepatitis are associated with the hemochromatosis mutation and increased liver damage. Gastroenterology 1998; 114: 311-8.
  • Turlin B, Juguet F, Moirand R, et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology 1995; 22: 446-50.
  • Deugnier YM, Charalambous P, Le Quilleuc D, et al. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993; 18: 1363-9.
  • Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981; 1293-4.
  • Lauffer RB. Iron stores and the international variation in mortality from coronary artery disease. Med Hypotheses 1990; 35: 96-102.
  • Miller M, Hutchins GM. Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease. J Am Med Assoc 1994; 272: 231-3.
  • Smith BC, Grove J, Guzail MA, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998; 27: 1695-9.
  • Barton JC, Harmon L, Rivers C, Acton RT. Hemochromatosis: association of severity of iron overload with genetic markers. Blood Cells Molecules Dis 1996; 22: 195-204.
  • Crawford DH, Halliday JW, Summers KM, et al. Concordance of iron storage in siblings with genetic hemochromatosis: evidence for a predominantly genetic effect on iron storage. Hepatology 1993; 17: 833-7.
  • Muir WA, McLaren GD, Braun W, Askari A. Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families. Am J Med 1984; 76: 806-14.
  • Adams PC. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 1994; 45: 146-9.
  • Bulaj ZJ, Griffen BA, Jorde LB, et al. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. New Engl J Med 1996; 335: 1799-805.
  • Borot N, Roth M, Malfroy L, et al. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997; 45: 320-4.
  • Sham RL, Ou CY, Cappuccio J, et al. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Blood Cells Molecules Dis 1997; 23: 314-20.
  • Crawford DH, Powell LW, Leggett BA, et al. Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 1995; 57: 362-7.
  • Crawford DHG, Jazwinska EC, Cullen LM, Powell L.W. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous subjects for the C282Y mutation. Gastroenterology 1998; 114: 1003-8.
  • Cox TM, Peters T. Uptake of iron by duodenal biopsy specimens from patients with iron deficiency anaemia and primary haemochromatosis. Lancet 1978; 1: 123-4.
  • Raja KB, Pountney D, Bomford A, et al. A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosis. Gut 1996; 38: 765-9.
  • Powell LW, Campbell CB, Wilson E. Intestinal mucosal uptake of iron and iron retention in idiopathic hemochromatosis as evidence of a mucosal abnormality. Gut 1970; 11: 727-31.
  • Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Nat Acad Sci USA 1998; 1477.
  • Fleming M, Trenor C, Su M, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997; 16: 383-6.
  • Gunshin H, Mackenzie B, Berger U, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-8.
  • Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric-oxide, and oxidative stress. Proc Natl Acad Sei USA 1996; 93: 8175-82.
  • Sciot R, Paterson AC, Van Den Ocrd JJ, Desmet VJ. Lack of hepatic transform receptor expression in hemochromatosis. Hepatology 1987; 7: 831-7.
  • Lombard M, Bomford A, Hynes M, et al. Regulation of the hepatic transform receptor in hereditary hemochromatosis. Hepatology 1989; 9: 1-5.
  • Pietrangelo A, Rocchi E, Rigo G, a al. Regulation of transferrin, transform receptor and ferritin gene expression in the duodenum of normal anemic and siderotic subjects. Gastroenterology 1992; 102: 802-9.
  • Flanagan PR, Hajdu A, Adams PC. Iron-responsive element-binding protein in hemochromatosis liver and intestine. Hepatology 1995; 22: 828-32.
  • Britton RS, Bacon BR, Recknagel RO. Lipid peroxidation and associated hepatic organelle dysfunction in iron overload. Chem Phys Lipids 1987; 45: 207-39.
  • Tavill AS, Sharma BK, Bacon BR. Iron and the liver: genetic hemochromatosis and other hepatic iron overload disorders. Prog Liver Dis 1990; 9: 281-305.
  • Young IS, Trouton TG, Torney JJ, et al. Genetic hemochromatosis and Wilson's Disease: role for oxidant stress? Free Radie Biol Med 1994; 16: 393-7.
  • Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr Opin Lipidol 1994; 5: 422-33.
  • Ramm GA, Halliday JW, Fletcher LM, et al. Hepatic stellate cell activation in genetic hemochromatosis: lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 1997; 26: 584-92.
  • Houglum K, Bedossa P, Chojkier M. TGF-B and collagen-al (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am J Physiol 1994; 5: G908-13.
  • Houglum K, Filip M, Witztum JL, Chojkier M. Malondialdehyde and 4-hydroxynoneal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990; 86: 1991-8.
  • Houglum K, Lee KS, Chojkier M. Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133. J Clin Invest 1997; 99: 1322-8.
  • Houglum K, Ramm GA, Crawford DHG, et al. Excess iron induces hepatic transforming growth factor Betal in genetic hemochromatosis: role of oxidative stress. Hepatology 1997; 27: 605-10.
  • Houglum K. Alcohol and iron: a radical combination? Hepatology 1996; 23: 1700-3.
  • Jazwinska EC, Lee SC, Webb SI, et al. Localization of the hemochromatosis gene close to D65105. Am J Hum Genet 1993; 53: 347-52.
  • Stone C, Pointon JJ, Jazwinska EC, et al. Isolation of CA dinucleotide repeats close to D65105; linkage disequilibrium with haemochromatosis. Hum MoI Genet 1994; 3: 2043-6.
  • Worwood M, Raha-Chowdhury R, Dorak M, Darke C, Bowen D, Burnett A. Alleles at D6S265 and D6S105 define a haemochromato sis-specific genotype. Br J of Haematol 1994; 86: 863-6.
  • Jazwinska EC, Pyper WR, Burt MJ, et al. Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am J Hum Genet 1995; 56: 428-33.
  • Raha-Chowdhury R, Bowen DJ, Stone C, et al. New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum MoI Genet 1995; 4: 1869-74.
  • Raha-Chowdhury R, Bowen D, Burnett A, Worwood M. Allelic associations and homozygosity in loci from HLA-B to D6S299 in genetic haemochromatosis. / Med Genet 1995; 32: 446-52.
  • Malfroy L, Roth MP, Carrington M et al. Heterogeneity in rates of recombination in the 6-Mb region telomeric to the human major histocompatibility complex. Genomics 1997; 43: 226-31.
  • Worwood M, Dorak MT, Nicklin S. The frequency of the haemochromatosis-associated genotype D6S265-1:D6S105-8 in blood donors. Br J Haematol 1996; 93: 838-40.
  • Campbell RD, Trowsdale J. Map of the human MHC. lmmunol Today 1993; 14: 349-52.
  • El Kalhoun A, Chauvel B, Mauvieux N, et al. Localization of seven new genes around the HLA-A locus. Hum MoI Genet 1993; 2: 55-60.
  • Abderrahim H, Sambucy JL, Iris F, et al. Cloning the human major histocompatibility complex in YACs. Genomics 1994; 23: 520-7.
  • Burt MJ, Smit DJ, Pyper WR, et al. A 4.5 megabase YAC contig and physical map over die hemochromatosis gene region. Genomics 1996; 33: 205-9.
  • Totaro A, Rommens JM, Grifa A. Hereditary hemochromatosis: generation of a transcription map within a refined and extended map of the HLA class I region. Genomics 1996; 31: 319-26.
  • Malaspina P, Roetto A, Trettel F, et al. Construction of a YAC contig covering human chromosome 6p22. Genomics 1996; 36: 399-407.
  • Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Molecules Dis 1996; 22: 187-94.
  • Bodmer JG, Parham P, Ekkehard DA, Marsh SGE. Putting a hold on "HLA-H". Nat Genet 1997; 15: 234-5.
  • Mercier B, Mura C, Ferec C. Putting a hold on "HLA-H". Nat Genet 1997; 15: 234-5.
  • Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. [letter; comment]. Am J Hum Genet 1997; 61: 762-4.
  • Beutler E. Genetic irony beyond haemochromatosis: clinical effect of HLA-H mutations. Lancet 1997; 349: 296-7.
  • Martinez PA, Biron C, Blanc F, et al. Compound heterozygotes for hemochromatosis gene mutations: may they help to understand the pathophysiology of the disease? Blood CeIls Molecules Dis 1997; 23: 269-76.
  • Risch R. Haemochromatosis, HFE and genetic complexity. Nat Genet 1997; 17: 375-6.
  • Lebron JA, Bennett MJ, Vaughn DE, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transform receptor. Cell 1998; 93: 111-23.
  • Parkkila S, Waheed A, Britton RS, et al. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastroentestinal tract. Proc Natl Acad Sci USA 1997; 94: 2534-9.
  • Bjorkman PJ, Parham P. Structure, function and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 1990; 59: 253-88.
  • Feder JN, Tsuchibashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts beta-2-microglobulin interaction and cell surface expression. J Biol Chem 1997; 272: 14025-8.
  • Waheed A, Parkkila S, Zhou XY, et al. Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with beta2microglobulin, intracellular processing and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997; 94: 12384-9.
  • Parkkila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997; 94: 13198-202.
  • Andersen GJ, Powell LW, Halliday JW. Transferrin receptor distribution and regulation in the rat small intestine: effect of iron stores and erythropoiesis. Gastroenterology 1990; 98: 576-85.
  • Banerjee D, Flanagan PR, Cluett J, Valberg LS. Transferrin receptors in the human gastrointestinal tract. Relationship to body iron stores. Gastroenterology 1986; 91: 861-9.
  • De Sousa M, Reimao R, Lacerda P, et al. Iron overload in beta2microglobulin deficient mice. Immunol Lett 1994; 39: 105-11.
  • Hashimoto K, Hirai M, Kurosawa Y. Identification of a mouse homolog for the human hereditary haemochromatosis candidate gene. Biochem Biophys Res Commun 1997; 230: 35-9.
  • Zhou XY, Tomatsu S, Fleming RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998; 95: 2492-7.
  • Lebouef RC, Toison D, Heinecke JW. Dissociation between tissue iron concentrations and transferrin saturation among inbred mouse strains. / Lab Clin Med 1995; 126: 128-36.
  • Yang B, Kirby S, Lewis J, et al. A mouse model for beta O-thalassemia. Proc Natl Acad Sci USA 1995; 92: 11608-12.
  • Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 1997; 94: 10919-24.
  • Craven CM, Alexander J, Eldridge M, et at. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse; a rodent model for hemochromatosis. Proc Natl Acad Sci USA 1987; 84: 3457-61.
  • Guyader D, Jacquelinet C, Moirand R, et al. Non-invasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastoenterology 1998; 115: 929-36.
  • Adams PC. Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis. Clin Genet 1998; 53: 176-8.
  • McLaren C, McLachlan G, Halliday J, et al. The distribution of transferrin saturation in an asymptomatic Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998; 114: 543-9.
  • Burke W, Thomson E, Khoury MI, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. J Am Med Assoc 1998; 280: 172-8.
  • Hickman P, Hourigan L, Powell LW, Crawford DHG. Automated measurement of unsaturated iron binding capacity allows a cost effective, ongoing strategy for screening for haemochromatosis. Hepatology 1998; 28: (4) 422A.
  • Niederau C, Fisher R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 125-62.
  • Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-19.
  • Baker ER, Monk CD, Do K, et al. The changing role of liver biopsy in hereditary haemochromatosis after the cloning of the HFE gene. Hepatology 1998; 28: 421A

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.